about
Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets?A genome-wide analysis of small regulatory RNAs in the human pathogen group A StreptococcusRegulatory RNAs in bacteriaAnalysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposureStructural basis for recognition of S-adenosylhomocysteine by riboswitchesThe structure of a tetrahydrofolate-sensing riboswitch reveals two ligand binding sites in a single aptamerCrystal structure of the lysine riboswitch regulatory mRNA elementFluorescence-Based Strategies to Investigate the Structure and Dynamics of Aptamer-Ligand ComplexesRecent Advances in Developing Small Molecules Targeting Nucleic AcidSmall molecules targeting viral RNALinking aptamer-ligand binding and expression platform folding in riboswitches: prospects for mechanistic modeling and designRecent advances and opportunities in synthetic logic gates engineering in living cellsStructure based approaches for targeting non-coding RNAs with small moleculesDiscrimination between Closely Related Cellular Metabolites by the SAM-I RiboswitchA Structural Basis for the Recognition of 2′-Deoxyguanosine by the Purine RiboswitchCoenzyme recognition and gene regulation by a flavin mononucleotide riboswitchThe Structural Basis for Recognition of the PreQ0 Metabolite by an Unusually Small Riboswitch Aptamer DomainAdaptive Ligand Binding by the Purine Riboswitch in the Recognition of Guanine and Adenine AnalogsNovel Ligands for a Purine Riboswitch Discovered by RNA-Ligand DockingComparison of a PreQ1 Riboswitch Aptamer in Metabolite-bound and Free States with Implications for Gene RegulationInsights into the Regulatory Landscape of the Lysine RiboswitchMolecular sensing by the aptamer domain of the FMN riboswitch: a general model for ligand binding by conformational selectionA Disconnect between High-Affinity Binding and Efficient Regulation by Antifolates and Purines in the Tetrahydrofolate RiboswitchSelective small-molecule inhibition of an RNA structural elementStructure and function of preQ1 riboswitchesNovel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathwaysRibozymes, riboswitches and beyond: regulation of gene expression without proteinsProspects for riboswitch discovery and analysisStructure-guided design of fluorescent S-adenosylmethionine analogs for a high-throughput screen to target SAM-I riboswitch RNAsPhylogenetic analysis and comparative genomics of purine riboswitch distribution in prokaryotesRiboswitches and the RNA worldStudying a Drug-like, RNA-Focused Small Molecule Library Identifies Compounds That Inhibit RNA Toxicity in Myotonic DystrophyA mechanism for S-adenosyl methionine assisted formation of a riboswitch conformation: a small molecule with a strong armDiscovering cis-regulatory RNAs in Shewanella genomes by Support Vector MachinesImprovement of RNA secondary structure prediction using RNase H cleavage and randomized oligonucleotides.Two-dimensional combinatorial screening of a bacterial rRNA A-site-like motif library: defining privileged asymmetric internal loops that bind aminoglycosides.Methods to enable the design of bioactive small molecules targeting RNA.The Staphylococcus aureus RNome and its commitment to virulence.Identification of novel ligands for thiamine pyrophosphate (TPP) riboswitches.Defining the RNA internal loops preferred by benzimidazole derivatives via 2D combinatorial screening and computational analysis
P2860
Q21032531-823D14D2-071D-471C-8B52-E14CAB1C9DE3Q21142714-42D2344C-BC81-41CE-9BAC-F89A4FCDD7A6Q24595082-30AD35CF-3ECF-4A98-B199-528B07D43338Q24596120-66C275A1-F911-4975-A603-80E8A349DDC6Q24630218-28F6C2A8-EF8F-400F-84D2-2CEDBE54D1D3Q24634946-1115C9EC-E7CE-49B2-A071-3A3D600FF580Q24646661-AE6C4DA1-593A-457A-A697-CBC4B40D5F4FQ26740493-445F93AB-1374-4C7B-BEB2-296B6E6F3103Q26744202-72431E88-EFDC-466C-BFFD-2FA9F6D5F722Q26745817-E7732677-EEAA-40A6-A418-9129C69CBE88Q26781454-A6BBCC44-703B-4E5E-92B2-81ABD9A27239Q26781904-2182B83D-AB81-4511-85E3-52B4FFF9CC11Q26858823-2FCAC7F6-7568-4A17-A8FC-090D61CBA05FQ27646576-00EFC82A-F866-45C7-8BBE-83008372976EQ27652897-3C8211A0-3095-43AE-8084-ED3F1FA05FC5Q27653517-6D31438B-70C4-4AB1-9C4A-F3F3E783007AQ27654015-E5E39379-68CA-4CCB-B0B7-B05DF0FD0571Q27655921-ED5C3C80-73FE-45EA-AC39-C98B4D6C383EQ27667324-406AB277-496C-485A-BBEC-1985E4677BC3Q27667887-D0DAE22C-EE63-422D-A765-51BC33C03D5CQ27670668-A0EB30A8-50D7-47BD-A3DC-695FB3B5E4CBQ27670760-D7B21C2B-0885-497D-974E-E98E8F6C1006Q27681170-A0439C87-CE9D-43AA-BD72-CB2D13F14880Q27702218-05EF0720-6912-4C11-8F22-91F84DE7BE9BQ28239535-6D80CA85-9EC4-4B09-A5D1-6E716666270CQ28473763-38DF2CAD-9BC5-437C-86BA-07B6BB418721Q28603616-7C84A267-C663-4925-BBC7-823158ABA06BQ28654385-5BAD2ECA-76F5-460F-9D4E-C25566606462Q28656519-C46D9F05-0F76-4472-8E05-C8321C6EB299Q28711956-B4FAA059-E7BC-4CAD-AE01-E62BB12EDAAEQ28732021-056BFEDB-C84A-4D7E-8B45-99E8AFC609B3Q28830592-2E4A3C95-406F-4406-A850-CBDAE04F6EBAQ30491321-E617D894-016D-437A-A7F9-AAB700697E77Q33426376-FC3886D6-0ECE-4A0D-9318-6976DBBDB4B8Q33481558-35E870FA-3455-407A-B34C-278A9417D9CBQ33527092-42C47EC7-8243-4EDC-9499-B2FFFC3B7130Q33609375-943EB2CF-A222-42D7-9A76-31002731722BQ33851489-860DE9C7-46B2-4716-9D2B-BC49D5935826Q33853175-1E40C349-5D93-4893-A4CC-6D680E4890D1Q33908985-9766B5DB-FDC4-4E99-B496-9682BD20D309
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Riboswitches as antibacterial drug targets.
@ast
Riboswitches as antibacterial drug targets.
@en
Riboswitches as antibacterial drug targets.
@nl
type
label
Riboswitches as antibacterial drug targets.
@ast
Riboswitches as antibacterial drug targets.
@en
Riboswitches as antibacterial drug targets.
@nl
prefLabel
Riboswitches as antibacterial drug targets.
@ast
Riboswitches as antibacterial drug targets.
@en
Riboswitches as antibacterial drug targets.
@nl
P356
P1433
P1476
Riboswitches as antibacterial drug targets.
@en
P2093
Kenneth F Blount
P2888
P304
P356
10.1038/NBT1268
P577
2006-12-01T00:00:00Z
P5875
P6179
1013763675